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Chlamydia infection. This suggests that VDR, CYP27B1, DHCR7, GC and CYP2R1 do not affect the susceptibility to Chlamydia infections. However, due to its pleiotropic nature in the immune system a role for the vitamin D pathway may not be excluded from the whole clinical course of Chlamydia infections (e.g. late complications), and further research is required.
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Chlamydia trachomatis (CT) is the most prevalent sexually transmitted bacterial infection in the world, with around 100 million new cases each year (WHO 2012) . The infection is often asymptomatic and frequently remains untreated due to late diagnosis, thereby resulting in late complications (Mabey 2014) . The clinical course of a CT infection varies greatly between individuals, and is in part mediated by immunogenetic factors (den Hartog et al. 2006; Al-Kuhlani et al. 2014; Branković et al. 2015) . These factors appear at this point to be the most promising biological indicators of complicated infection with Chlamydiae. (Malogajski et al. 2013) .
Investigations of the role of the active form of vitamin D [1,25-(OH) 2 D 3 ] within different types of cells of the immune system demonstrate its immunomodulatory properties (White 2008; Hewison and Litwack 2011) . All types of immune cells, but also 'barrier surface' cells such as epithelial cells, can respond to the stimulation by 1,25-(OH) 2 D 3 (Hewison and Litwack 2011) . In monocytes and macrophages the synthesis of vitamin D active form from its circulating form by 25hydroxyvitamin-D-1α-hydroxylase (also referred to as 1-OHase, encoded by CYP27B1) is regulated via mechanisms entirely independent of calcium metabolism (Stoffels et al. 2006) . Exposure to certain bacterial species affects local expression of genes within vitamin D biopathway, including that of antimicrobial peptides-cathelicidins and defensins (Wang et al. 2004; Liu et al. 2006) . Sensing of specific bacterial components by patternrecognition-receptors triggers changes in the local vitamin D metabolism in immune cells, upregulating the expression of the aforementioned 1-OHase, but also of vitamin D receptor (VDR) (Liu et al. 2006) . He et al. (2013) observed in their murine model study that genital chlamydial infection was more severe and prolonged in VDR −/− knockout mice compared to VDR +/+ mice. It has been shown that VDR acts as a transcription factor for genes for cathelicidins and defensins (Wang et al. 2004) . These peptides were also demonstrably bactericidal when applied in vitro to CT (Yasin et al. 1996; Donati et al. 2005) . Hence, we assume that depletion of antimicrobial peptides in response to insufficient levels of vitamin D's active form could potentially lead to less effective eradication of this pathogen.
Lack of vitamin D may therefore lead to heightened risk of developing an infection due to the compromised antibacterial actions of the immune system and barrier tissues. The availability of the circulating form, however, also depends on the vitamin D metabolic pathway components, not only on the receptors (Hewison and Litwack 2011) . Polymorphisms in genes for conversion enzymes, transport molecules and the VDR may therefore all affect host defence via the change in bioavailability of 1,25-(OH) 2 D 3 and its activation of transcription-regulating functions of the VDR (Jurutka et al. 2000) .
Genetic differences in genes involved in biosynthesis, serum transport and cellular conversion of vitamin D and its precursors and metabolites have been shown to influence bioavailability of vitamin D in humans, as well as health status for various infec-tions (Hansdottir et al. 2008; Roth et al. 2008; Moodley et al. 2013 ). To date, no studies examining polymorphisms within genes of the vitamin D biopathway and CT have been published. Therefore, we conduct an analysis of polymorphisms with reported functional effect on vitamin D metabolism.
We investigated whether there were differences in susceptibility to urogenital CT infection in humans, based on polymorphisms within the following genes of the vitamin D pathway: VDR, CYP2R1, DHCR7, GC and CYP27B1.
In the study, we used vaginal samples obtained from a STD outpatient clinic in the southern part of Limburg, the Netherlands. We selected Dutch Caucasian women for this study, all between 18 and33 years of age. Chlamydia status was assessed by the outpatient clinic using the available NAAT assay. All women were asked to sign an informed consent. The Medical Research Involving Human Subjects Act (WMO, Dutch Law) stated that official approval of the study by the Medical Ethical Committee does not apply to our anonymous human material collected (MEC Letter reference: no. 10.17.0046). The local medical ethical committee also approved this study, based on the fact that in the Netherlands ethical approval is not required for a retrospective use of de-identified clinical samples. Since we performed host genetic marker studies in relation to Chlamydial infection, we nevertheless made sure all participants signed informed consent forms.
We selected polymorphisms for analysis based on the literature featured in Genetic Associations database, as well as PubMed searches using terms 'vitamin D', 'polymorphism OR SNP' and 'infection'. Polymorphisms with either a proven or theoretical functional impact (either amino acid change, or impact on protein expression) and/or haplotype tagging were eligible for inclusion in this study. Effects in previous studies of the vitamin D pathway increased eligibility. Only polymorphisms with minor allele frequencies higher than 5% were considered (based on the data in NCBI SNP database, dbSNP). We included SNPs from the following genes:
, GC (rs3755967) and CYP2R1 (rs10741657 G > A, rs2060793 G > A). All polymorphisms were genotyped by LGC Genomics using their own form of competitive allele-specific PCR (KASP) and using Roche LightCycler 480 Real-Time PCR under standard conditions.
Groups were tested for Hardy-Weinberg Equilibrium to assess Mendelian Inheritance. Fisher Exact and χ 2 tests were used where appropriate. A P-value < 0.05 was considered statistically significant.
The genotype frequencies of the eight studied SNPs were in Hardy-Weinberg equilibrium. Differences in genotype distribution between CT positive and CT negative women were tested with Fisher Exact and/or χ 2 tests, and are presented in Table 1 .
We did not observe statistically significant differences in genotype distributions of these eight SNPs between CT positive and CT negative women, and between CT positive women by guest on March 5, 2016 http://femspd.oxfordjournals.org/ Downloaded from with or without symptoms. Some near-trend values were observed, however these were lost when corrections for multiple testing were taken into account. These results may indicate a lack of statistical power. Carrier traits, or combinations of polymorphisms, may influence the susceptibility to Chlamydia infections, however due to lack of sufficient sample numbers, carrier trait analyses were not performed. Our findings might be the result of obscured true effects due to modulation by other polymorphisms. VDR encodes the intracellular VDR which is involved in the regulation of transcription for a number of genes and can form dimers with RXR-α, including those genes whose products are involved in antimicrobial defence. The effects of mutant allele of VDR rs1544410 may thus be modulated by particular variations in the gene encoding the RXR-α protein, given their potential for interaction and gene expression alterations. Successive studies should take into account potential interactions between polymorphisms in these two genes and investigate the nature of the interaction.
The studied SNPs have been described to affect the vitamin D pathway in literature. Due to the nature of the samples (vaginal swabs) we were not able to assess the vitamin D serum levels of the participating women. Further studies are needed to elu-cidate whether or not the studied SNPs correlate to vitamin D serum levels in this cohort.
It is possible that vitamin D-induced antibacterial peptides are not crucial for susceptibility to CT infection in humans the same way they appear to be in cases of several other diseases. Although their bactericidal capacity was demonstrated in several in vitro studies of CT infections (Yasin et al. 1996; Donati et al. 2005) , more studies are required to elucidate whether these peptides are effective against CT within host cells. Their effect might also vary depending on the stage of the chlamydial biological cycle.
In conclusion, our case-control study did not register any associations between functional polymorphisms in the vitamin D biopathway and susceptibility to Chlamydia infections. This does not exclude a potential role for the vitamin D pathway in the severity of Chlamydia infections (e.g. development of tubal pathology). Other studies point to a more complex relationship between circulating levels of vitamin D, its intracellular conversion rate into the active form, expression of vitamin D response genes and their regulation of the innate and adaptive immunity. Further research is needed to elucidate these processes and explain how these actions exert their effect and by guest on March 5, 2016 http://femspd.oxfordjournals.org/ Downloaded from whether there are disease-specific properties differ from their previously researched pleiotropic involvements in inflammatory conditions underlying for instance cancer, tissue injury and atherosclerosis.
